share_log

Novartis AG | F-6 POS: Post-effective amendment to a F-6EF registration

Dec 16, 2022 15:42
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more